Abstract: Compositions comprising a linear base polymer, an ethylenically unsaturated addition-polymerizable compound and a combination of (A) a 1-benzoyl-1-amino-substituted-1-benzylalkane with (B) an .alpha.-phenyl-.alpha.,.alpha.-dialkoxyacetophenone as photopolymerization initiator are suitable for the production of thick-film printing plates.

Abstract: .delta.-Amino-.gamma.-hydroxy-.omega.

Abstract: Disclosed are the compounds of formula I ##STR1## wherein X represents oxo, one hydroxy or lower alkoxy and one hydrogen, or two hydrogens;R.sub.a and R.sub.b independently represent hydrogen, hydroxy, lower alkoxy, nitro, amino or halogen; or R.sub.a and R.sub.b on adjacent carbons taken together represent lower alkylenedioxy;R.sub.c represents hydrogen, lower alkyl or aryl-lower alkyl;R represents hydrogen or acyl;R.sub.1 represents hydrogen, lower alkyl, aryl, aryl-lower alkyl, cycloalkyl, cycloalkyl-lower alkyl, biaryl, biaryl-lower alkyl or trifluoromethyl;R.sub.2 represents hydrogen or lower alkyl; or R.sub.1 and R.sub.2 together with the carbon to which they are attached represent cycloalkylene or benzo-fused cycloalkylene;m represents one or two;n represents zero or one;COOR.sub.

Abstract: Recycled plastics, predominanty thermoplastics, from domestic, commercial and industrial waste can be stabilized against thermooxidative degradation by adding a combination of a sterically hindered phenol with an organic phosphite or phosphonite and a metal salt of a fatty acid.

Abstract: An apparatus for a process for wet-treating seeds with an acaricidal, fungicidal, insecticidal or nutritive agent which consists of a foam-forming apparatus comprising a first foam-formation chamber equipped with openings which allow a gas and the aqueous composition containing at least one nonphytotoxic foaming agent to be admitted and containing, downstream of these openings, at least one sieve, this first chamber continuing into a second chamber for compressing and structuring the foam, which ends in an outlet nozzle for the foam.

Abstract: Compounds of formula I ##STR1## or their hydroxy-protected derivatives, and compounds of formula I' ##STR2## wherein T is an acyl radical of formula Z ##STR3## wherein R.sup.z is unsubstituted or substituted hydrocarbyl wherein at least one carbon atom has been replaced by a hetero atom with the proviso that a hetero atom is not bonded directly to the carbonyl to which the radical R.sup.z is bonded, alkyl having two or more carbon atoms, lower alkenyl, lower alkynyl, aryl or unsubstituted or substituted amino, and wherein the radicals R.sub.1, B.sub.1, R.sub.2, R.sub.3, A.sub.1, A.sub.2 and NR.sub.4 R.sub.5 are as defined in the description, and precursors thereof, are described. The compounds have pharmaceutical activity, for example in the treatment of retroviral diseases, such as AIDS.

Abstract: Azo dyes of the formula (1) ##STR1## in which R.sub.1 and R.sub.2 are hydrogen or C.sub.1 -C.sub.4 alkyl, R.sub.3, R.sub.4, R.sub.5 and R.sub.6 are hydrogen, C.sub.1 -C.sub.4 alkyl, C.sub.1 -C.sub.4 alkoxy, C.sub.2 -C.sub.4 alkanoylamino, ureido or halogen, X is chlorine or fluorine, B.sub.1 is phenyl, naphthyl or heterocyclic radical, and A.sub.1 is a radical of the formula (2) ##STR2## in which R.sup.7 is hydrogen, amino, N-mono- or N,N-di-C.sub.1 -C.sub.4 alkylamino or optionally substituted phenylamino and R.sub.8 is hydrogen or hydroxyl, or A.sub.1 is a radical of the formula (3) ##STR3## in which R.sub.9 is hydrogen, C.sub.1 -C.sub.8 alkyl or phenyl which is optionally substituted by C.sub.1 -C.sub.4 alkyl, C.sub.1 -C.sub.4 alkoxy, C.sub.2 -C.sub.2 -C.sub.4 alkanoylamino, ureido, halogen or sulfo, R.sub.10 is hydrogen or C.sub.1 -C.sub.8 alkyl and R.sub.11 is hydrogen, C.sub.1 -C.sub.4 alkyl, C.sub.1 -C.sub.4 alkoxy, C.sub.2 -C.sub.

Abstract: The present invention is directed to the production of an antipathogenic substance (APS) in a host via recombinant expression of the polypeptides needed to biologically synthesize the APS. Genes encoding polypeptides necessary to produce particular antipathogenic substances are provided, along with methods for identifying and isolating genes needed to recombinantly biosynthesize any desired APS. The cloned genes may be transformed and expressed in a desired host organisms to produce the APS according to the invention for a variety of purposes, including protecting the host from a pathogen, developing the host as a biocontrol agent, and producing large, uniform amounts of the APS.

Abstract: The invention relates to a novel process for stereocontrolled preparation of 1',1'-disubstituted and 1'-spiro-nucleosides of the formula I ##STR1## in which the substituents A, R.sub.8 and R.sub.9 are as defined in claim 1, and to novel intermediates and their use in this process and to processes for the preparation of the novel intermediates. The process is illustrated by the example of biologically active (+)-hydantocidin.

Abstract: Heat-stable, red pigment compositions comprising a physical mixture of 1,4-diketo-3,6-di(4-biphenylyl)-pyrrolo [3,4 c]-pyrrole and a 2,9-dichloroquinacridone pigments, processes for preparing the pigment compositions and the use of the compositions for pigmenting high-molecular-weight organic materials are disclosed.

Abstract: The present invention relates to novel substituted thiosemicarbazone derivatives of formula (I) wherein R.sub.1 is lower alkyl, lower alk-2-en-1-yl, lower alk-2-yn-1-yl, or aryl-lower alkyl, R.sub.2 is hydrogen, lower alkyl, aryl, aryl-lower alkyl, lower alk-2-en-1-yl, lower alk-2-yn-1-yl, unsaturated or saturated heterocyclyl-lower alkyl, lower alkoxycarbonyl-lower alkyl or the group --C(.dbd.O)--R.sub.3, wherein R.sub.3 is lower alkyl, aryl, aryl-lower alkyl, aryl-lower alkenyl, heteroaryl (betaryl), aryloxy, aryl-lower alkoxy or lower alk-2-en-1-yloxy, and the salts thereof, to a process for the preparation of said compounds, to pharmaceutical compositions containing them, and to the use thereof as medicaments.

Abstract: Pigment compositions comprising an organic pigment whose particle surface is provided with a protective coating layer, which coating comprises(a) a metal phosphate complex in which the metal is selected from the group consisting of, zirconium, titanium and mixtures thereof in a quantity of from 0.5 to 100% by weight, preferably to 20% by weight, particularly preferably from 1 to 10% by weight, based on the pigment; and(b) an amine or ammonium salt, in a quantity of from 0.5 to 15% by weight, preferably up to 10% by weight, particularly preferably up to 5% by weight, based on the pigment. The compositions are distinguished by outstanding properties, especially by the high gloss of the colorations obtained therewith, by very good dispersibility, high dispersion stability and heat resistance and by very good rheological characteristics of the paint millbases or printing inks prepared therewith. The plastics pigmented with the compositions of the invention are likewise distinguished by good dispersibility.

Abstract: The invention concerns proteins having glycosyltransferase activity, recombinant DNA molecules encoding proteins having glycosyltransferase activity, hybrid vectors comprising such recombinant DNA molecules, transformed hosts suitable for the multiplication and/or expression of the recombinant DNA molecules, and processes for the preparation of the proteins, DNA molecules and hosts.

Abstract: Compounds of formula I ##STR1## wherein R.sub.1 is a 2-R.sub.A -3-R.sub.B -phenyl radical, a 2-R.sub.A -4-R.sub.C -phenyl radical, a 2-R.sub.A -pyridin-3-yl radical, a 3-R.sub.A -pyridin-2-yl radical or a 1-R.sub.D -indol-3-yl radical, wherein one of the radicals R.sub.A and R.sub.B is an aliphatic or heterocycloaliphatic-aliphatic radical or free or aliphatically, araliphatically or heteroaraliphatically etherified hydroxy and the other is hydrogen, an aliphatic radical or free or esterified or amidated carboxy, R.sub.C is hydrogen, an aliphatic radical, free or aliphatically, araliphatically, heteroaraliphatically or heteroarylaliphatically etherified hydroxy or an unsubstituted or heteroaliphatically substituted amino group, and R.sub.D is an aliphatic, araliphatic or heteroaliphatic radical, one of the radicals X.sub.1 and X.sub.2 is carbonyl and the other is methylene, R.sub.2 is an aliphatic radical, R.sub.3 is unsubstituted or aliphatically substituted amino, R.sub.

Abstract: The invention relates to phthalocyanines and metal complexes thereof with divalent metals or divalent oxo metals, which contain at least one phosphorus-containing substituent bonded to the peripheral carbon skeleton via the phosphorus atom.The compounds preferably conform to the general structural formula (G).sub.k -A-(Q).sub.l, in which A is a phthalocyanine or metal complex thereof with a divalent metal or a divalent oxo metal, G is a phosphorus-containing substituent, Q is a further substituent as defined below, the index k is a number from 1 to 16, and l, independently thereof, is 0 or a number from 1 to 15, with the proviso that the sum of k and l is a number less than or equal to 16.The invention also relates to a material for the optical recording and storage of information, in which at least one storage layer (2) of a novel phthalocyanine compound or a metal complex thereof has been applied to a transparent, dielectric carrier material (1).

Abstract: A dispensing device having a container body defining a solution retaining chamber therein, the container having an outlet for dispensing the solution from the chamber and means for removing a component from the solution as the solution is dispensed from the chamber through the container outlet. A method is provided for administering to a patient a pharmacologically active substance which substance is stable only at a pH value which is extreme in the acidic or alkaline region and at which pH value the substance cannot be administered without causing discomfort and/or injury to the patient. The substance is maintained in a solution or dispersion at the pH at which it is stable until the time of administration. At this time the substance is administered through a chamber containing an ion exchange resin which changes the pH of the solution or dispersion to a value which will not cause discomfort and/or injury to the patient.

Abstract: The invention relates to nucleosides, nucleotides and oligonucleotides carrying in their basic structure a primary hydroxyl group protected by tris-4,4',4"-tert-butylphenylmethyl, to processes for the preparation of said nucleosides and nucleotides, to a process for the preparation of oligonucleotides, and to the use of said protected nucleosides, nucleotides and oligonucleotides.

Abstract: The present invention is directed to the production of an antipathogenic substance (APS) in a host via recombinant expression of the polypeptides needed to biologically synthesize the APS. Genes encoding polypeptides necessary to produce particular antipathogenic substances are provided, along with methods for identifying and isolating genes needed to recombinantly biosynthesize any desired APS. The cloned genes may be transformed and expressed in a desired host organisms to produce the APS according to the invention for a variety of purposes, including protecting the host from a pathogen, developing the host as a biocontrol agent, and producing large, uniform amounts of the APS.

Abstract: Azo dyes of formula ##STR1## wherein R.sub.1 and R.sub.2 are each independently of the other hydrogen or unsubstituted or substituted C.sub.1 -C.sub.4 alkyl,R.sub.3, R.sub.4, R.sub.5, R.sub.6 and R.sub.7 are each independently of one another hydrogen, halogen, sulfo, carbamoyl, carboxy, unsubstituted or hydroxy-substituted C.sub.1 -C.sub.4 alkyl or C.sub.1 -C.sub.4 alkoxy;C.sub.2 -C.sub.4 alkanoylamino which is unsubstituted or substituted in the alkyl moiety by hydroxy or C.sub.1 -C.sub.4 alkoxy, or ureido which is unsubstituted or substituted in the amino end group by one or two C.sub.1 -C.sub.4 alkyl groups,Y.sub.1 is hydroxy, halogen, C.sub.1 -C.sub.4 alkoxy, C.sub.1 -C.sub.4 alkylthio, amino; N-mono-C.sub.1 -C.sub.4 alkylamino or N,N-di-C.sub.1 -C.sub.4 alkylamino, each of which is unsubstituted or substituted in the alkyl moiety by hydroxy, sulfo, carboxy or C.sub.1 -C.sub.4 alkoxy; C.sub.5 -C.sub.7 cycloalkylamino which is unsubstituted or substituted in the cycloalkyl ring by C.sub.1 -C.sub.

Abstract: Compounds of formula I ##STR1## wherein A, X, Z and R.sub.1 -R.sub.5 are as defined in the description, and their salts have valuable pharmaceutical properties and are effective especially against tumours. They are prepared in a manner known per se.